http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Tue, 28 Jul 2026 10:01:48 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Equity+Offerings/Instinct+Bio+signs+term+sheet+for+%24150M+equity+purchase+facility/26824059.html <p>Instinct Bio Technical Company Holdings Inc. (Nasdaq: BIOT) announced it has entered into an indicative term sheet for a proposed equity purchase facility that would allow the company to sell up to $150 million of its common stock over a three-year period, according to a press release.</p><p>Under the proposed terms, the company would have the right, but not the obligation, to direct share purchases at a price generally based on the volume-weighted average price of its common stock on the applicable purchase date, less a specified discount.</p><p>The company said proceeds would be used to develop its regenerative medicine platform, fund http://www.streetinsider.com/Equity+Offerings/Instinct+Bio+signs+term+sheet+for+%24150M+equity+purchase+facility/26824059.html Tue, 28 Jul 2026 10:01:48 -0400 ACQC BIOT http://www.streetinsider.com/Equity+Offerings/Instinct+Bio+signs+term+sheet+for+%24150M+equity+purchase+facility/26824059.html <p>Instinct Bio Technical Company Holdings Inc. (Nasdaq: BIOT) announced it has entered into an indicative term sheet for a proposed equity purchase facility that would allow the company to sell up to $150 million of its common stock over a three-year period, according to a press release.</p><p>Under the proposed terms, the company would have the right, but not the obligation, to direct share purchases at a price generally based on the volume-weighted average price of its common stock on the applicable purchase date, less a specified discount.</p><p>The company said proceeds would be used to develop its regenerative medicine platform, fund http://www.streetinsider.com/Equity+Offerings/Instinct+Bio+signs+term+sheet+for+%24150M+equity+purchase+facility/26824059.html Tue, 28 Jul 2026 10:01:48 -0400 ACQC BIOT http://www.streetinsider.com/Corporate+News/Instinct+Bio+signs+term+sheet+for+%24150M+equity+purchase+facility/26824059.html <p>Instinct Bio Technical Company Holdings Inc. (Nasdaq: BIOT) announced it has entered into an indicative term sheet for a proposed equity purchase facility that would allow the company to sell up to $150 million of its common stock over a three-year period, according to a press release.</p><p>Under the proposed terms, the company would have the right, but not the obligation, to direct share purchases at a price generally based on the volume-weighted average price of its common stock on the applicable purchase date, less a specified discount.</p><p>The company said proceeds would be used to develop its regenerative medicine platform, fund http://www.streetinsider.com/Corporate+News/Instinct+Bio+signs+term+sheet+for+%24150M+equity+purchase+facility/26824059.html Tue, 28 Jul 2026 10:01:48 -0400 ACQC BIOT http://www.streetinsider.com/Corporate+News/Instinct+Bio+signs+term+sheet+for+%24150M+equity+purchase+facility/26824059.html <p>Instinct Bio Technical Company Holdings Inc. (Nasdaq: BIOT) announced it has entered into an indicative term sheet for a proposed equity purchase facility that would allow the company to sell up to $150 million of its common stock over a three-year period, according to a press release.</p><p>Under the proposed terms, the company would have the right, but not the obligation, to direct share purchases at a price generally based on the volume-weighted average price of its common stock on the applicable purchase date, less a specified discount.</p><p>The company said proceeds would be used to develop its regenerative medicine platform, fund http://www.streetinsider.com/Corporate+News/Instinct+Bio+signs+term+sheet+for+%24150M+equity+purchase+facility/26824059.html Tue, 28 Jul 2026 10:01:48 -0400 ACQC BIOT http://www.streetinsider.com/Hot+Corp.+News/Instinct+Bio+signs+term+sheet+for+%24150M+equity+purchase+facility/26824059.html <p>Instinct Bio Technical Company Holdings Inc. (Nasdaq: BIOT) announced it has entered into an indicative term sheet for a proposed equity purchase facility that would allow the company to sell up to $150 million of its common stock over a three-year period, according to a press release.</p><p>Under the proposed terms, the company would have the right, but not the obligation, to direct share purchases at a price generally based on the volume-weighted average price of its common stock on the applicable purchase date, less a specified discount.</p><p>The company said proceeds would be used to develop its regenerative medicine platform, fund http://www.streetinsider.com/Hot+Corp.+News/Instinct+Bio+signs+term+sheet+for+%24150M+equity+purchase+facility/26824059.html Tue, 28 Jul 2026 10:01:48 -0400 ACQC BIOT http://www.streetinsider.com/Hot+Corp.+News/Instinct+Bio+signs+term+sheet+for+%24150M+equity+purchase+facility/26824059.html <p>Instinct Bio Technical Company Holdings Inc. (Nasdaq: BIOT) announced it has entered into an indicative term sheet for a proposed equity purchase facility that would allow the company to sell up to $150 million of its common stock over a three-year period, according to a press release.</p><p>Under the proposed terms, the company would have the right, but not the obligation, to direct share purchases at a price generally based on the volume-weighted average price of its common stock on the applicable purchase date, less a specified discount.</p><p>The company said proceeds would be used to develop its regenerative medicine platform, fund http://www.streetinsider.com/Hot+Corp.+News/Instinct+Bio+signs+term+sheet+for+%24150M+equity+purchase+facility/26824059.html Tue, 28 Jul 2026 10:01:48 -0400 ACQC BIOT http://www.streetinsider.com/Press+Releases/Instinct+Bio+%28Nasdaq%3A+BIOT%29+Secures+%24150+Million+Equity+Funding+to+Advance+Regenerative+Medicine+Platform+and+Strategic+Growth/26824053.html <p>New York, NY, July 28, 2026 (GLOBE NEWSWIRE) -- <strong>INSTINCT BIO TECHNICAL COMPANY HOLDINGS INC</strong><strong>.</strong> (Nasdaq: <strong>BIOT</strong>) (&quot;Instinct Bio&quot; or the &quot;Company&quot;) today announced that it has entered into an indicative term sheet (“Term Sheet”) relating to a proposed equity purchase facility that would provide the Company with the ability to sell up to US$150 million of its common stock over a three-year period.</p> <p>Under the terms outlined in the Term Sheet, the Company would have the right, but not the obligation, to direct the purchase of shares of the Company’s common stock from http://www.streetinsider.com/Press+Releases/Instinct+Bio+%28Nasdaq%3A+BIOT%29+Secures+%24150+Million+Equity+Funding+to+Advance+Regenerative+Medicine+Platform+and+Strategic+Growth/26824053.html Tue, 28 Jul 2026 10:01:00 -0400 A.50217033 ACQC O.53499456 http://www.streetinsider.com/Press+Releases/Instinct+Bio+%28Nasdaq%3A+BIOT%29+Secures+%24150+Million+Equity+Funding+to+Advance+Regenerative+Medicine+Platform+and+Strategic+Growth/26824053.html <p>New York, NY, July 28, 2026 (GLOBE NEWSWIRE) -- <strong>INSTINCT BIO TECHNICAL COMPANY HOLDINGS INC</strong><strong>.</strong> (Nasdaq: <strong>BIOT</strong>) (&quot;Instinct Bio&quot; or the &quot;Company&quot;) today announced that it has entered into an indicative term sheet (“Term Sheet”) relating to a proposed equity purchase facility that would provide the Company with the ability to sell up to US$150 million of its common stock over a three-year period.</p> <p>Under the terms outlined in the Term Sheet, the Company would have the right, but not the obligation, to direct the purchase of shares of the Company’s common stock from http://www.streetinsider.com/Press+Releases/Instinct+Bio+%28Nasdaq%3A+BIOT%29+Secures+%24150+Million+Equity+Funding+to+Advance+Regenerative+Medicine+Platform+and+Strategic+Growth/26824053.html Tue, 28 Jul 2026 10:01:00 -0400 A.50217033 ACQC O.53499456 http://www.streetinsider.com/Press+Releases/Instinct+Bio+%28Nasdaq%3A+BIOT%29+Secures+%24150+Million+Equity+Funding+to+Advance+Regenerative+Medicine+Platform+and+Strategic+Growth/26824053.html <p>New York, NY, July 28, 2026 (GLOBE NEWSWIRE) -- <strong>INSTINCT BIO TECHNICAL COMPANY HOLDINGS INC</strong><strong>.</strong> (Nasdaq: <strong>BIOT</strong>) (&quot;Instinct Bio&quot; or the &quot;Company&quot;) today announced that it has entered into an indicative term sheet (“Term Sheet”) relating to a proposed equity purchase facility that would provide the Company with the ability to sell up to US$150 million of its common stock over a three-year period.</p> <p>Under the terms outlined in the Term Sheet, the Company would have the right, but not the obligation, to direct the purchase of shares of the Company’s common stock from http://www.streetinsider.com/Press+Releases/Instinct+Bio+%28Nasdaq%3A+BIOT%29+Secures+%24150+Million+Equity+Funding+to+Advance+Regenerative+Medicine+Platform+and+Strategic+Growth/26824053.html Tue, 28 Jul 2026 10:01:00 -0400 A.50217033 ACQC O.53499456 http://www.streetinsider.com/Globe+Newswire/Instinct+Bio+%28Nasdaq%3A+BIOT%29+Secures+%24150+Million+Equity+Funding+to+Advance+Regenerative+Medicine+Platform+and+Strategic+Growth/26824053.html <p>New York, NY, July 28, 2026 (GLOBE NEWSWIRE) -- <strong>INSTINCT BIO TECHNICAL COMPANY HOLDINGS INC</strong><strong>.</strong> (Nasdaq: <strong>BIOT</strong>) (&quot;Instinct Bio&quot; or the &quot;Company&quot;) today announced that it has entered into an indicative term sheet (“Term Sheet”) relating to a proposed equity purchase facility that would provide the Company with the ability to sell up to US$150 million of its common stock over a three-year period.</p> <p>Under the terms outlined in the Term Sheet, the Company would have the right, but not the obligation, to direct the purchase of shares of the Company’s common stock from http://www.streetinsider.com/Globe+Newswire/Instinct+Bio+%28Nasdaq%3A+BIOT%29+Secures+%24150+Million+Equity+Funding+to+Advance+Regenerative+Medicine+Platform+and+Strategic+Growth/26824053.html Tue, 28 Jul 2026 10:01:00 -0400 A.50217033 ACQC O.53499456 http://www.streetinsider.com/Globe+Newswire/Instinct+Bio+%28Nasdaq%3A+BIOT%29+Secures+%24150+Million+Equity+Funding+to+Advance+Regenerative+Medicine+Platform+and+Strategic+Growth/26824053.html <p>New York, NY, July 28, 2026 (GLOBE NEWSWIRE) -- <strong>INSTINCT BIO TECHNICAL COMPANY HOLDINGS INC</strong><strong>.</strong> (Nasdaq: <strong>BIOT</strong>) (&quot;Instinct Bio&quot; or the &quot;Company&quot;) today announced that it has entered into an indicative term sheet (“Term Sheet”) relating to a proposed equity purchase facility that would provide the Company with the ability to sell up to US$150 million of its common stock over a three-year period.</p> <p>Under the terms outlined in the Term Sheet, the Company would have the right, but not the obligation, to direct the purchase of shares of the Company’s common stock from http://www.streetinsider.com/Globe+Newswire/Instinct+Bio+%28Nasdaq%3A+BIOT%29+Secures+%24150+Million+Equity+Funding+to+Advance+Regenerative+Medicine+Platform+and+Strategic+Growth/26824053.html Tue, 28 Jul 2026 10:01:00 -0400 A.50217033 ACQC O.53499456 http://www.streetinsider.com/Globe+Newswire/Instinct+Bio+%28Nasdaq%3A+BIOT%29+Secures+%24150+Million+Equity+Funding+to+Advance+Regenerative+Medicine+Platform+and+Strategic+Growth/26824053.html <p>New York, NY, July 28, 2026 (GLOBE NEWSWIRE) -- <strong>INSTINCT BIO TECHNICAL COMPANY HOLDINGS INC</strong><strong>.</strong> (Nasdaq: <strong>BIOT</strong>) (&quot;Instinct Bio&quot; or the &quot;Company&quot;) today announced that it has entered into an indicative term sheet (“Term Sheet”) relating to a proposed equity purchase facility that would provide the Company with the ability to sell up to US$150 million of its common stock over a three-year period.</p> <p>Under the terms outlined in the Term Sheet, the Company would have the right, but not the obligation, to direct the purchase of shares of the Company’s common stock from http://www.streetinsider.com/Globe+Newswire/Instinct+Bio+%28Nasdaq%3A+BIOT%29+Secures+%24150+Million+Equity+Funding+to+Advance+Regenerative+Medicine+Platform+and+Strategic+Growth/26824053.html Tue, 28 Jul 2026 10:01:00 -0400 A.50217033 ACQC O.53499456 http://www.streetinsider.com/Mergers+and+Acquisitions/Instinct+Bio+begins+Nasdaq+trading+via+SPAC+merger+at+%24288M+value/26808245.html <p>Instinct Bio Technical Company Holdings Inc. completed its business combination with Relativity Acquisition Corp. (OTC: ACQC), a special purpose acquisition company, and began trading on the Nasdaq Stock Market under the ticker symbol NASDAQ: BIOT on July 24, 2026.</p> <p>The combined company carries a pro forma enterprise value of approximately $288 million at closing. Warrants are trading under the symbol "BIOTW."</p> <p>Instinct Bio describes itself as an integrated regenerative medicine and longevity company focused on the research, manufacturing, and commercialization of stem cell-derived products, wellness solutions, and skincare. The company is headquartered in Tokyo, Japan, with operations also in Las Vegas and http://www.streetinsider.com/Mergers+and+Acquisitions/Instinct+Bio+begins+Nasdaq+trading+via+SPAC+merger+at+%24288M+value/26808245.html Thu, 23 Jul 2026 16:15:17 -0400 ACQC BIOT RACY http://www.streetinsider.com/Mergers+and+Acquisitions/Instinct+Bio+begins+Nasdaq+trading+via+SPAC+merger+at+%24288M+value/26808245.html <p>Instinct Bio Technical Company Holdings Inc. completed its business combination with Relativity Acquisition Corp. (OTC: ACQC), a special purpose acquisition company, and began trading on the Nasdaq Stock Market under the ticker symbol NASDAQ: BIOT on July 24, 2026.</p> <p>The combined company carries a pro forma enterprise value of approximately $288 million at closing. Warrants are trading under the symbol "BIOTW."</p> <p>Instinct Bio describes itself as an integrated regenerative medicine and longevity company focused on the research, manufacturing, and commercialization of stem cell-derived products, wellness solutions, and skincare. The company is headquartered in Tokyo, Japan, with operations also in Las Vegas and http://www.streetinsider.com/Mergers+and+Acquisitions/Instinct+Bio+begins+Nasdaq+trading+via+SPAC+merger+at+%24288M+value/26808245.html Thu, 23 Jul 2026 16:15:17 -0400 ACQC BIOT RACY http://www.streetinsider.com/Mergers+and+Acquisitions/Instinct+Bio+begins+Nasdaq+trading+via+SPAC+merger+at+%24288M+value/26808245.html <p>Instinct Bio Technical Company Holdings Inc. completed its business combination with Relativity Acquisition Corp. (OTC: ACQC), a special purpose acquisition company, and began trading on the Nasdaq Stock Market under the ticker symbol NASDAQ: BIOT on July 24, 2026.</p> <p>The combined company carries a pro forma enterprise value of approximately $288 million at closing. Warrants are trading under the symbol "BIOTW."</p> <p>Instinct Bio describes itself as an integrated regenerative medicine and longevity company focused on the research, manufacturing, and commercialization of stem cell-derived products, wellness solutions, and skincare. The company is headquartered in Tokyo, Japan, with operations also in Las Vegas and http://www.streetinsider.com/Mergers+and+Acquisitions/Instinct+Bio+begins+Nasdaq+trading+via+SPAC+merger+at+%24288M+value/26808245.html Thu, 23 Jul 2026 16:15:17 -0400 ACQC BIOT RACY